TGase2 Antibodies

Santa Cruz Biotechnology features a diverse variety of TGase2 monoclonal antibodies for investigating transglutaminase 2 (TGase2) in various biological processes. TGase2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Transglutaminase 2 functions as a multifunctional enzyme involved in protein cross-linking, cell adhesion, and apoptosis, playing a vital role in tissue repair and remodeling. TGase2 dysregulation has been linked to various diseases, including cancer and neurodegenerative disorders, making it an important target for therapeutic intervention. Researchers can utilize TGase2 monoclonal antibodies to explore cellular mechanisms and disease pathways. Understanding TGase2 function and regulation can lead to breakthroughs in disease treatment strategies. Investigating TGase2 expression patterns helps reveal its role in normal physiology and pathological conditions. Current research focuses on understanding how TGase2 contributes to disease progression and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TGase2 and its impact on human health.